Michael R Johnston

Michael R Johnston

UNVERIFIED PROFILE

Are you Michael R Johnston?   Register this Author

Register author
Michael R Johnston

Michael R Johnston

Publications by authors named "Michael R Johnston"

Are you Michael R Johnston?   Register this Author

39Publications

772Reads

29Profile Views

Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma.

Clin Cancer Res 2017 Feb 28;23(4):1060-1067. Epub 2016 Sep 28.

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0844DOI Listing
February 2017

Plant Polyphenols as Chemopreventive Agents for Lung Cancer.

Int J Mol Sci 2016 Aug 19;17(8). Epub 2016 Aug 19.

Department of Environmental Sciences, Faculty of Agriculture, Dalhousie University, P.O. Box 550, Truro, NS B2N 5E3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms17081352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000748PMC
August 2016

Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.

J Thorac Oncol 2014 Oct;9(10):1449-58

*The Canadian Centre for Applied Research in Cancer Control, and the British Columbia Cancer Agency, Vancouver, British Columbia, Canada; †The British Columbia Cancer Agency, Vancouver, British Columbia, Canada; ‡Brock University, St. Catherines, Ontario, Canada; §Cancer Care Ontario and the Juravinski Cancer Centre, Hamilton, Ontario, Canada; ‖University Health Network and Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ¶The Canadian Centre for Applied Research in Cancer Control, the British Columbia Cancer Agency and School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; #The University of British Columbia School of Population and Public Health, Vancouver, British Columbia, Canada; **Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada; ††The British Columbia Cancer Agency and The Canadian Centre for Applied Research in Cancer Control and the University of British Columbia, Vancouver, British Columbia, Canada; ‡‡Beatrice Hunter Cancer Research Institute and Dalhousie University, Halifax, Nova Scotia, Canada; §§The Vancouver General Hospital, Vancouver, British Columbia, Canada; ‖‖Fionna Stanley Hospital and Sir Charles Gairdner Hospital, Perth, Western Australia; ¶¶Université Laval, Québec, Canada; ##Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; ***The Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada; †††Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ‡‡‡University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada; §§§Foothills Medical Centre, Calgary, Alberta, Canada; ‖‖‖Memorial University, St. Johns, Newfoundland, Canada; ¶¶¶The Ottawa Hospital, Ottawa, Ontario, Canada; ###Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; ****The Vancouver General Hospital and The University of British Columbia, Vancouver, British

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165479PMC
October 2014

Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.

J Clin Oncol 2013 Nov 3;31(33):4179-87. Epub 2013 Sep 3.

Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston; David H. Johnson, University of Texas Southwestern, Dallas, TX; Sandra J. Lee, Dana-Farber Cancer Institute, Boston, MA; Steven M. Keller, Montefiore Medical Center, Bronx, NY; Gail Shaw Wright, Florida Cancer Specialists, New Port Richey, FL; Seena Aisner, University of Medicine and Dentistry of New Jersey/New Jersey Medical School Cancer Institute of New Jersey, Newark, NJ; Steven Alan Belinsky, Lovelace Respiratory Research Institute, Albuquerque, NM; Gary Goodman, Swedish Medical Center Cancer Institute; Gary Goodman, Fred Hutchinson Cancer Research Center, Seattle, WA; Gerald Clamon, University of Iowa, Iowa City, IA; Randolph Marks, Mayo Clinic, Rochester, MN; Worta McCaskill-Stevens, National Cancer Institute, Rockville, MD; Scott M. Lippman, University of California San Diego Cancer Center, San Diego, CA; John Ruckdeschel, Intermountain Healthcare, Salt Lake City, UT; Fadlo R. Khuri, Emory University, Atlanta, GA; Michael R. Johnston, Dalhousie University, Halifax, Nova Scotia; Michael R. Johnston, National Cancer Institute of Canada Clinical Trials Group, Kingston; Gordon Okawara, McMaster University, Hamilton, Ontario; and Eric Frechette, Hopital Laval, Quebec City, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821010PMC
November 2013

Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: A new approach.

Cancer Lett 2010 Nov 26;297(1):126-36. Epub 2010 May 26.

Toronto General Research Institute, University Health Network, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2010.05.005DOI Listing
November 2010

Pathologic assessment of radiofrequency ablation of pulmonary metastases.

J Vasc Interv Radiol 2010 Nov 29;21(11):1689-96. Epub 2010 Sep 29.

Mount Sinai Hospital, Department of Medical Imaging, Room 564, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2010.06.023DOI Listing
November 2010

Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.

J Immunol 2010 Jul 14;185(2):956-66. Epub 2010 Jun 14.

Latner Thoracic Surgery Research Laboratories, University Health Network, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0900437DOI Listing
July 2010

Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors.

BMC Cancer 2010 Jun 14;10:285. Epub 2010 Jun 14.

Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, 60 Murray St, Toronto M5T3L9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927994PMC
June 2010

Implementation of real-time ultrasound in a thoracic surgery practice.

Ann Thorac Surg 2009 May;87(5):1577-81

Thoracic Surgery & Lung Transplant, Department of Surgery, Toronto General Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2008.12.024DOI Listing
May 2009

Initial treatment strategies and outcomes for multifocal bronchioloalveolar carcinoma.

Clin Lung Cancer 2009 May;10(3):187-92

Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2009.n.026DOI Listing
May 2009

Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.

Cancer Res 2009 Feb 27;69(3):1174-81. Epub 2009 Jan 27.

Department of Pharmaceutical Science, Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-1753DOI Listing
February 2009

Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma.

Ann Thorac Surg 2008 Apr;85(4):1206-10

Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2007.11.065DOI Listing
April 2008

Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.

J Thorac Cardiovasc Surg 2008 Apr;135(4):823-9

Division of Thoracic Surgery, Toronto General Hospital, University Health Network, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2007.10.026DOI Listing
April 2008

A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.

Biomaterials 2007 Jul 24;28(21):3236-44. Epub 2007 Mar 24.

Institute of Medical Science and Department of Surgery, Faculty of Medicine, University of Toronto, Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2007.03.022DOI Listing
July 2007

Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

J Thorac Cardiovasc Surg 2007 Jan;133(1):111-6

Division of Thoracic Surgery, Toronto General Hospital, University of Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2006.06.044DOI Listing
January 2007

Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model.

J Thorac Oncol 2006 Oct;1(8):771-9

Division of Thoracic Surgery, Toronto General Hospital, University Health Network and the Department of Surgery and Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
October 2006

Targeting colloidal particulates to thoracic lymph nodes.

Lung Cancer 2006 Mar 18;51(3):377-86. Epub 2006 Jan 18.

Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2005.11.006DOI Listing
March 2006

An unusual cause of syncope.

Asian Cardiovasc Thorac Ann 2005 Dec;13(4):400

Division of Cardiovascular Surgery, Toronto General Hospital, The University of Toronto, 200 Elizabeth Street, Toronto, Ontario M5G2C4, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/021849230501300426DOI Listing
December 2005

Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection.

Neoplasia 2004 Nov-Dec;6(6):761-7

University Health Network, Ontario Cancer Institute/Princess Margaret Hospital, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1593/neo.04301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1531680PMC
April 2005

Preoperative assessment: an anesthesiologist's perspective.

Thorac Surg Clin 2005 Feb;15(1):11-25

Department of Anesthesia, University of Toronto, and The University Health Network, Toronto General Hospital, 3EN 200 Elizabeth Street, Toronto, ON, Canada, M5G 2C4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thorsurg.2004.08.003DOI Listing
February 2005

Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.

Lung Cancer 2004 Nov;46(2):197-204

Division of Cellular and Molecular Biology, University Health Network, Ontario Cancer Institute, Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada M5G 2M9.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020400155
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2004.04.002DOI Listing
November 2004

Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasis.

Oncogene 2004 Aug;23(37):6316-24

Division of Thoracic Surgery, University Health Network, Princess Margaret Hospital and Ontario Cancer Institute, Ontario, Canada M5G 2M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207795DOI Listing
August 2004

Expression of chicken ovalbumin upstream promoter-transcription factor II enhances invasiveness of human lung carcinoma cells.

Cancer Res 2004 Aug;64(15):5097-105

Lung Biology Research Programme and Canadian Institutes of Health Research Group in Lung Development, The Hospital for Sick Children, 555 University Avenue, Montreal, Quebec, Canada M5G 1X8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-03-1185DOI Listing
August 2004

Massive primary chest wall chondrosarcoma.

Eur J Cardiothorac Surg 2004 Jun;25(6):1124-5

Toronto General Hospital, Division of Thoracic Surgery, Suite 10 EN-2230, 200 Elizabeth Street, Toronto, Ont., Canada M5G 2C4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcts.2004.02.042DOI Listing
June 2004

Early combined treatment with carboplatin and the MMP inhibitor, prinomastat, prolongs survival and reduces systemic metastasis in an aggressive orthotopic lung cancer model.

Lung Cancer 2003 Dec;42(3):335-44

Department of Surgery, Division of Thoracic Surgery, Toronto General Hospital, University of Toronto, Suite 10 EN-230, 200 Elizabeth Street, Toronto, Ont., Canada M5G2C4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(03)00355-6DOI Listing
December 2003

Induction therapy for stage III lung cancer.

Lung Cancer 2003 Dec;42 Suppl 2:S53-7

University of Toronto, Toronto General Hospital, 200 Elizabeth Street, Suite 10 EN-230, Toronto, Ont, Canada M5G 2C4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2003.08.012DOI Listing
December 2003

Predicting length of stay out of hospital following lung resection using preoperative health status measures.

Qual Life Res 2003 Sep;12(6):645-54

Department of Research, Toronto Rehabilitation Institute, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1025147906867DOI Listing
September 2003

Lung cancer in the 21st century.

Surg Oncol 2002 Dec;11(4):165

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-7404(02)00052-xDOI Listing
December 2002

Animal models for studying lung cancer and evaluating novel intervention strategies.

Surg Oncol 2002 Dec;11(4):217-27

Department of Thoracic Surgery, Toronto General Hospital, Division of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-7404(02)00053-1DOI Listing
December 2002

Novel candidate tumor marker genes for lung adenocarcinoma.

Oncogene 2002 Oct;21(49):7598-604

University Health Network - Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205953DOI Listing
October 2002